PubMed HealthSearch

Biomedical subjects

P Lundgren

Publications and source records attributed to P Lundgren.

At least 19 recordsLinked to original sources

Morphological and GABA-immunoreactive development of the embryonic chick telencephalon.

The development of neurons utilizing gamma-aminobutyric acid (GABAergic neurons) in prosencephalon and telencephalon from chicken embryonic days 4-14 (E4-E14) was studied by means of immunohistochemistry. Furthermore, routine histology and transmission electron microscopy. respectively, were performed in order to study the morphological development in the designated area. The main finding is that development of GABAergic neurons in the chick telencephalon is rapid; the GABA neurons are appearing in bulk at day 8, being "overexpressed" at days 10-11, decreasing in numbers thereafter and achieving mature morphology on day 14, which is considerably faster than in the rodent. Morphological analysis revealed that the prosencephalon mainly consisted of a thin layer of undifferentiated neuroblasts in the E4 embryo. By E6, the prosencephalon had increased in thickness and occasional cells outside the neuroepithelium showed a more mature morphology with a few cells weakly staining positive for GABA. At E8, the prospective granular and subventricular layers had developed. At E14, the appearance of the telencephalon is approximating that of the adult since both ependymal cells and morphologically mature neurons can be seen.

Animals

In vitro release of anthralin from white petrolatum and an o/w cream.

A method to study the in vitro release of anthralin from ointments was developed. A diffusion cell with an artificial membrane (dialysis membrane) was used. As the solubility of anthralin in water is extremely low, methanol was chosen as receptor phase. The temperature at the membrane was kept constant at 32 degrees C during the release study. At appropriate intervals samples were withdrawn and assayed by HPLC. The in vitro release of anthralin from white petrolatum and a cream containing 70% oil in water (Locobase) was studied in a concentration range of 0.04-3.0%. Both ointments showed a faster release with increasing concentration of anthralin. The in vitro release of anthralin from the cream was significantly faster than from white petrolatum.

Anthralin

Studies on the evaluation of preservative efficacy--II. The determination of antimicrobial characteristics of benzylalcohol.

A successful kinetic approach to the screening of preservation efficacy of benzylalcohol--a neutral-type preservative--is described. The D-value, activation energy (Ea), temperature coefficient (Q10) and concentration exponent (n) were used as parameters in determining the influence of different factors on the efficacy of benzylalcohol. Factors, such as the pH of the solution, temperature and concentration of the preservative were investigated. The study was carried out using five micro-organisms: Aspergillus niger, Candida albicans, Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus.

Bacteria

A study of routines followed and equipment used in 430 hospital wards handling antineoplastic agents.

The routines followed and the equipment used by hospital staff when handling antineoplastic drugs were studied. A questionnaire was sent via the hospital pharmacies to hospital wards which administered antineoplastic drugs at least once a week. The answers received from 430 wards indicate a good understanding and awareness of the risks. Efforts had been made to protect the personnel from potential adverse effects. Efforts had been made to protect the personnel from potential adverse effects from the medications prepared or administered. There was, however, still a shortage of protective equipment such as ventilated cabinets. Existing cabinets were often not used and maintained in a proper manner. On the basis of the responses to the questionnaire, it may be concluded that there is still a need for further evaluation of the routines used in the practical handling of antineoplastic agents in hospital wards.

Antineoplastic Agents